
Infinity Pharmaceuticals INFI
Quarterly report 2023-Q2
added 05-16-2026
Infinity Pharmaceuticals P/CF Ratio 2011-2026 | INFI
Annual P/CF Ratio Infinity Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.4 | -4.74 | -3.55 | -1.32 | -13.9 | -2.8 | -0.64 | -3.38 | 6.44 | -5.81 | -17.8 | -7.11 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.44 | -17.8 | -4.58 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-117 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.14 | 0.16 % | $ 653 M | ||
|
Eton Pharmaceuticals
ETON
|
53.1 | $ 35.05 | 1.73 % | $ 943 M | ||
|
Forte Biosciences
FBRX
|
-6.59 | $ 22.24 | 9.5 % | $ 288 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-0.379 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.195 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
48.3 | $ 91.28 | 1.02 % | $ 22.1 B | ||
|
Grifols, S.A.
GRFS
|
5.01 | $ 8.12 | -0.92 % | $ 5.52 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.66 | 2.16 % | $ 442 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
-7.19 | $ 0.88 | 3.88 % | $ 147 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
6.2 | $ 2.62 | -3.33 % | $ 245 M | ||
|
Anika Therapeutics
ANIK
|
19.1 | $ 15.05 | -0.59 % | $ 216 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
13.8 | $ 97.57 | 0.5 % | $ 19 B | ||
|
Ionis Pharmaceuticals
IONS
|
-48.1 | $ 76.17 | 1.47 % | $ 12.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.205 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.44 | 3.61 % | $ 5.66 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
-1.63 | $ 1.6 | 5.63 % | $ 187 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 20.96 | 2.37 % | $ 2.67 B | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M |